The University of New Mexico Hospitals is renewing its annual subscription to Wolters Kluwer’s UpToDate LexiDrug drug‑reference platform through a sole‑source contract. The renewal ensures uninterrupted access to an evidence‑based, integrated clinical decision‑support tool that is embedded in the hospital’s electronic health‑record system. Because the content and platform are proprietary, the agency justifies a non‑competitive award to avoid patient‑safety risks and costly re‑implementation.
• 1‑year license renewal valued at $78,946.59, covering July 1 2025 – June 30 2026.
• Proprietary software (Wolters Kluwer) is the sole source for LexiDrug content and technical support.
• The contract supports pharmacists, physicians, nurses, and other clinicians with drug monographs, interaction checks, pharmacogenomics, and patient‑education tools, fully integrated into UNMH’s workflow.
• Renewal option is available under New Mexico Statute 13‑1‑150, allowing future extensions without a new competition.
• No alternative vendors were solicited, and the sole‑source justification cites continuity of care and risk mitigation as primary reasons.